Replies to post #19289 on Livechain Inc (LICH)

[timez1000]

Also saw a reference for the average cost for phase 1,2, and 3 clinical trials for a dermatology (topical) drug is around $22 million total, so they may already have enough funding for phase 3 clinical trials.